Ii-Key/HER2/neu cancer vaccine cancer data

GNBT's AE37 breast cancer vaccine significantly reduced regulatory T cells after 6 months in all 6 vaccinated patients (p=0.002). Researchers said that fewer regulatory T cells, which inhibit immune r...